Drug Profile
Interferon-alpha Omniferon - Viragen
Alternative Names: alpha-IF; Natural human interferon-alpha; Natural human leukocyte interferon-alpha; OmniferonLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Viragen; ViraNative
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Haematological malignancies; Hepatitis C; Herpes simplex virus infections; HIV infections; Leukaemia; Multiple sclerosis
Most Recent Events
- 28 Sep 2001 Suspended-II for Hepatitis C in Europe (SC)
- 29 Jun 2001 Viragen has received UK approval to begin clinical trials with OmniferonTM for the treatment of multiple sclerosis
- 09 Feb 2001 Pall Corporation will supply leukocytes fo Viragen for manufacture of OmniferonTM